Editorial Comment from Dr Hirayama and Dr Iguchi to Cranial nerve palsy caused by metastasis to the skull base in patients with castration-resistant prostate cancer: Three case reports
- PMID: 33718821
- PMCID: PMC7924078
- DOI: 10.1002/iju5.12265
Editorial Comment from Dr Hirayama and Dr Iguchi to Cranial nerve palsy caused by metastasis to the skull base in patients with castration-resistant prostate cancer: Three case reports
Conflict of interest statement
Taro Iguchi has obtained research funding from Bayer and Astellas, has served as a consultant or advisor from Bayer and Astellas, has participated in the speakers’ bureau for Bayer, Janssen, Sanofi, and Astellas.
References
-
- Laigle‐Donadey F, Taillibert S, Martin‐Duverneuil N, Hildebrand J, Delattre JY. Skull‐base metastases. J. Neurooncol. 2005; 75: 63–9. - PubMed
-
- McDermott RS, Anderson PR, Greenberg RE, Milestone BN, Hudes GR. Cranial nerve deficits in patients with metastatic prostate carcinoma: clinical features and treatment outcomes. Cancer 2004; 101: 1639–43. - PubMed
-
- O'Sullivan JM, Norman AR, McNair H, Dearnaley DP. Cranial nerve palsies in metastatic prostate cancer – results of base of skull radiotherapy. Radiother. Oncol. 2004; 70: 87–90. - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Other Literature Sources